Bath & Body Works (NYSE:BBWI – Get Rating) was downgraded by equities researchers at Argus from a “buy” rating to a “hold” rating in a research report issued on Friday, MarketBeat reports.
Several other equities analysts have also commented on the company. Raymond James lowered their price objective on Bath & Body Works from $52.00 to $50.00 and set a “strong-buy” rating for the company in a research report on Friday, February 24th. Bank of America lifted their price target on Bath & Body Works from $48.00 to $50.00 in a research report on Thursday, November 17th. Credit Suisse Group lifted their price target on Bath & Body Works from $42.00 to $46.00 and gave the stock a “neutral” rating in a research report on Friday, February 24th. Jefferies Financial Group lifted their price target on Bath & Body Works from $45.00 to $52.00 and gave the stock a “buy” rating in a research report on Tuesday, January 31st. Finally, Barclays lifted their price target on Bath & Body Works from $39.00 to $43.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 22nd. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Bath & Body Works presently has a consensus rating of “Moderate Buy” and a consensus target price of $49.52.
Bath & Body Works Trading Down 2.3 %
Shares of Bath & Body Works stock opened at $34.43 on Friday. The firm has a market capitalization of $7.86 billion, a P/E ratio of 9.98, a P/E/G ratio of 0.95 and a beta of 1.77. The business has a fifty day simple moving average of $42.85 and a two-hundred day simple moving average of $39.54. Bath & Body Works has a 12 month low of $25.75 and a 12 month high of $58.17.
Institutional Inflows and Outflows
About Bath & Body Works
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Further Reading
- Get a free copy of the StockNews.com research report on Bath & Body Works (BBWI)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.